ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | -100.0% | 135 | -98.9% | 0.00% | – |
| Q1 2021 | $42,000 | -82.4% | 12,400 | 0.0% | 0.00% | – |
| Q4 2020 | $238,000 | +42.5% | 12,400 | 0.0% | 0.00% | – |
| Q3 2020 | $167,000 | -68.2% | 12,400 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $525,000 | +90.2% | 12,400 | +24.0% | 0.00% | – |
| Q1 2020 | $276,000 | -15.1% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $325,000 | +41.9% | 10,000 | +13.6% | 0.00% | – |
| Q3 2019 | $229,000 | -29.1% | 8,800 | 0.0% | 0.00% | – |
| Q2 2019 | $323,000 | +65.6% | 8,800 | 0.0% | 0.00% | – |
| Q1 2019 | $195,000 | +57.3% | 8,800 | 0.0% | 0.00% | – |
| Q4 2018 | $124,000 | -27.5% | 8,800 | 0.0% | 0.00% | – |
| Q3 2018 | $171,000 | -11.9% | 8,800 | 0.0% | 0.00% | – |
| Q2 2018 | $194,000 | +118.0% | 8,800 | +109.5% | 0.00% | – |
| Q1 2018 | $89,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |